Genotype-Related Efficacy and Adverse Effects of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder. (2022). Precision Medicine Communications, 2(1), 27-42. https://doi.org/10.55627/pmc.002.01.0044